Health Condition 1: F42- Obsessive-compulsive disorder
Conditions
Interventions
Intervention1: Fluvoxamine 50 mg once daily for 12 weeks initially and can be increased upto
250 mg, if required.: Assess efficacy using Y BOCS Scale and CGI scale at baseline,2,4,6, and 12 weeks.
Saf
Sponsors
PT B.D Sharma UHS Rohtak
Eligibility
Inclusion criteria
Inclusion criteria: 1)Age 18-65 years 2)Patient fulfilling the criteria of OCD as per ICD-11 any severity YBOCS score more than 8. 3) Willing to participate and give informed consent
Exclusion criteria
Exclusion criteria: 1) Current diagnosis of OCD with psychotic features or any other psychiatric diagnosis in the past 2) Patient with a history of any chronic physical illness 3) Current psychoactive substance use â?¢ Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement in Y- BOCS scale 2. Improvement in CGI scaleTimepoint: Baseline,2,4,6 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Number of patients who withdrew from study due to ADRâ??s of drugs. 2. Number of patients requiring augmentation of fluvoxamine therapy 3.Mean dose of fluvoxamine required in both groupsTimepoint: 1.Safety assessment will be carried out for both the treatment groups at 2, 4, 6 and 12 weeks. 2.drug response at the end of 2,4,6 and 12 weeks | — |
Countries
India
Contacts
Public ContactDr Ekta Sharma
PT B.D. SHARMA UNIVERSITY OF HEALTH SCIENCE PGIMS ROHTAK
Outcome results
None listed